On the heels of a previously-reported cyberattack on the European Medicines Agency (EMA), cybercriminals have spilled compromised data related to COVID-19 vaccinations onto the internet. The EMA is an agency of the European Union in charge of the evaluation and supervision of medicinal products in the E.U, similar to the FDA in the U.S. In December, the agency disclosed that threat actors broke into its server and accessed documentation about the vaccine from Pfizer and BioNTech. Specifically accessed were some documents relating to the regulatory submission for the companies’ COVID-19 vaccine candidate, BNT162b2, which was stored on the EMA server, a Pfizer spokesperson confirmed to Threatpost. Fast forward to this week, when “the ongoing investigation of the cyberattack on EMA revealed that some of the unlawfully accessed documents related to COVID-19 medicines and vaccines belonging to third parties have been leaked on the internet.” According to a Tuesday update from the EMA on its website, “necessary action is being taken by the law-enforcement authorities.” The EMA has not disclosed detailed specifics of the cyberattack, including the timeframe, the initial point of compromise and what specific data on these regulatory submission documents was accessed. In its Tuesday update, it said it continues to notify “additional entities and individuals whose documents and personal data may have been subject to unauthorized access.” However, the networks of the EMA remain fully…
Our Standard Office Hours
Monday – Friday: 8:00AM – 5:00PM EDT
Saturday – Sunday: Closed
Where to Find Us
205 Rockingham Row, Princeton, NJ 08540
315 West 36th Street, New York, NY 10018
(212) 696-0500
hello@govanguard.com
PGP: 0xE5D39775A0C6351B
For more information about PGP please see “What PGP is, and why You should use it”.
Data Privacy Notice
Content Notice
- – All product names, logos, and brands are property of their respective owners.
- – The use of these names, logos, and brands is for identification purposes only and does not imply endorsement.
- – Content syndication and aggregation of public information is solely for the purpose of identifying information security trends, all syndicated content contains source links to the content creator website. All content is owned by it’s respective content creators.
- – If you are an owner of some content and want it to be removed, please email hello@gvit.com